Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
1 study found for:    22789511 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXA
Condition: Hepatitis B
Interventions: Biological: HBVaxPRO® 5 µg / 0.5 mL;   Biological: Engerix B® 10 µg / 0.5 mL
To Top

† Indicates status has not been verified in more than two years